Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients

NCT03977051 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2024-04-12

Study results available
· View outcomes & findings →

Summary

To describe the beliefs, understanding and experience of immunosuppressant medication adherence in our current transplant patient population through a series of patient focus groups

Conditions

  • Adherence, Medication
  • Transplantation, Kidney

Interventions

BEHAVIORAL

Focus group

Kidneys transplant patients will discuss their attitudes and beliefs towards immunosuppressant medication adherence

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Dawn Goodall, MSC, BSc · Imperial College Healthcare NHS Trust

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-08
Primary Completion
2017-06-20
Completion
2017-06-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03977051 on ClinicalTrials.gov